17-beta-hydroxysteroid dehydrogenase deficiency molecular genetic studies: Difference between revisions
No edit summary |
No edit summary |
||
Line 10: | Line 10: | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Endocrinology | [[Category:Endocrinology]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] |
Revision as of 20:03, 19 September 2012
17-beta-hydroxysteroid dehydrogenase deficiency Microchapters |
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
17-beta-hydroxysteroid dehydrogenase deficiency molecular genetic studies On the Web |
American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency molecular genetic studies |
FDA on 17-beta-hydroxysteroid dehydrogenase deficiency molecular genetic studies |
CDC on 17-beta-hydroxysteroid dehydrogenase deficiency molecular genetic studies |
17-beta-hydroxysteroid dehydrogenase deficiency molecular genetic studies in the news |
Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency molecular genetic studies |
Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Genetic Studies
17-beta-hydroxysteroid dehydrogenase deficiency-3 is caused by gene mutations found in the 17BHSD3 gene. 17-beta-hydroxysteroid dehydrogenase deficiency-3 is an autosomal recessive disorder.